<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39370869</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Epidemiological and clinical characteristics of adenovirus-associated respiratory tract infection in children in Hangzhou, China, 2019-2024.</ArticleTitle><Pagination><StartPage>e29957</StartPage><MedlinePgn>e29957</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29957</ELocationID><Abstract><AbstractText>This study aimed to assess the impact of COVID-19 on the prevalence of adenovirus (AdV) infection in children. This study retrospectively analyzed the changes in the epidemiological and clinical features of AdV-associated respiratory infections in children in Hangzhou, China, between January 2019 and July 2024. A total of 771 316 samples were included in the study, and the positive rate was 6.10% (47 050/771 316). Among them, the positive rate of AdV infection was highest in 2019, reaching 11.29% (26 929/238 333), while the positive rates in the remaining years were between 2% and 9%. In terms of seasonal epidemic characteristics, the summer of 2019 was the peak of AdV incidence, with the positive rate peaking at around 16.95% (7275/45 268), followed by a gradual decline and a low-level epidemic in winter, with a positive rate of 8.79% (8094/92 060). However, during the period 2020-2024, the AdV epidemic season did not show any significant regularity. Gender analysis revealed that the positive rate of male patients was generally greater than that of female patients. In different age groups, the population susceptible to AdV changed before and after the epidemic. In the early and middle stages of the COVID-19 epidemic, the susceptible population was mainly 2-5 years old, whereas in the later stages of the epidemic, the susceptible population was 5-18 years old. In addition, the main clinical symptoms of AdV-positive children from 2019-2024 were respiratory tract symptoms and fever. In summary, the COVID-19 epidemic has had a certain impact on the prevalence of AdV. These findings provide an important basis and reference for the prevention and diagnosis of AdV, especially in the context of increasing age- and gender-specific public health strategies.</AbstractText><CopyrightInformation>© 2024 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Haiyun</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0008-8569-6962</Identifier><AffiliationInfo><Affiliation>Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Danlei</ForeName><Initials>D</Initials><Identifier Source="ORCID">0009-0007-9475-6261</Identifier><AffiliationInfo><Affiliation>Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ru</LastName><ForeName>Xuanwen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Qingyi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Simiao</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ruiying</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Jiayi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-6756-0630</Identifier><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Dongqing</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="Y">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000258" MajorTopicYN="N">Adenovirus Infections, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000257" MajorTopicYN="N">Adenoviridae Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000256" MajorTopicYN="N">Adenoviridae</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000260" MajorTopicYN="N">Adenoviruses, Human</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adenovirus</Keyword><Keyword MajorTopicYN="N">clinical features</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">respiratory infections</Keyword><Keyword MajorTopicYN="N">retrospective studies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>3</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39370869</ArticleId><ArticleId IdType="doi">10.1002/jmv.29957</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>MacNeil KM, Dodge MJ, Evans AM, Tessier TM, Weinberg JB, Mymryk JS. Adenoviruses in medicine: innocuous pathogen, predator, or partner. Trends Mol Med. 2023;29:4‐19.</Citation></Reference><Reference><Citation>Killerby ME, Rozwadowski F, Lu X, et al. Respiratory illness associated with emergent human adenovirus genome type 7d, New Jersey, 2016−2017. Open Forum Infect Dis. 2019;6:ofz017.</Citation></Reference><Reference><Citation>Schaberg KB, Kambham N, Sibley RK, Higgins JPT. Adenovirus hepatitis: clinicopathologic analysis of 12 consecutive cases from a single institution. Am J Surg Pathol. 2017;41:810‐819.</Citation></Reference><Reference><Citation>Campbell SJ, Kynyk JA, Davis JA. Disseminated adenovirus infection causing severe ARDS. BMJ Case Rep. 2017;2017:bcr2016217524. doi:10.1136/bcr-2016-217524</Citation></Reference><Reference><Citation>Zhang Y, Huang W, Ornelles DA, Gooding LR. Modeling adenovirus latency in human lymphocyte cell lines. J Virol. 2010;84:8799‐8810.</Citation></Reference><Reference><Citation>Hum RM, Deambrosis D, Lum SH, et al. Molecular monitoring of adenovirus reactivation in faeces after haematopoietic stem‐cell transplantation to predict systemic infection: a retrospective cohort study. Lancet Haematol. 2018;5:e422‐e429.</Citation></Reference><Reference><Citation>Kosulin K, Pichler H, Lawitschka A, Geyeregger R, Lion T. Diagnostic parameters of adenoviremia in pediatric stem cell transplant recipients. Front Microbiol. 2019;10:414.</Citation></Reference><Reference><Citation>Proenca‐Modena JL, de Souza Cardoso R, Criado MF, et al. Human adenovirus replication and persistence in hypertrophic adenoids and palatine tonsils in children. J Med Virol. 2019;91:1250‐1262.</Citation></Reference><Reference><Citation>Kosulin K, Geiger E, Vécsei A, et al. Persistence and reactivation of human adenoviruses in the gastrointestinal tract. Clin Microbiol Infect. 2016;22:381.e1‐381.e8.</Citation></Reference><Reference><Citation>Lynch JP, Kajon AE. Adenovirus: epidemiology, global spread of novel types, and approach to treatment. Semin Respir Crit Care Med. 2021;42:800‐821.</Citation></Reference><Reference><Citation>Ye Q, Liu H. Impact of non‐pharmaceutical interventions during the COVID‐19 pandemic on common childhood respiratory viruses—an epidemiological study based on hospital data. Microb Infect. 2022;24:104911.</Citation></Reference><Reference><Citation>Ye Q, Liu H, Mao J, Shu Q. Nonpharmaceutical interventions for COVID‐19 disrupt the dynamic balance between influenza A virus and human immunity. J Med Virol. 2023;95:e28292.</Citation></Reference><Reference><Citation>Ye Q, Wang D. Epidemiological changes of common respiratory viruses in children during the COVID‐19 pandemic. J Med Virol. 2022;94:1990‐1997.</Citation></Reference><Reference><Citation>Chen D, Zhang T, Chen S, et al. The effect of nonpharmaceutical interventions on influenza virus transmission. Front Pub Health. 2024;12:1336077.</Citation></Reference><Reference><Citation>Chen D, Ru X, Chen S, Shao Q, Ye Q. Analysis of the prevalence and clinical features of respiratory syncytial virus infection in a pediatric hospital in Zhejiang Province from 2019 to 2023. J Med Virol. 2024;96:e29758.</Citation></Reference><Reference><Citation>State Key Laboratory for Diagnosis and Treatment of Infectious Diseases. &amp; National Clinical Research Center for Infectious Diseases. Expert consensus on clinical diagnosis and treatment of respiratory tract infection during multi‐pathogen epidemic. Chin J Clin Infect Dis. 2023;16:419.</Citation></Reference><Reference><Citation>Cheng JL, Peng CC, Chiu NC, et al. Risk factor analysis and molecular epidemiology of respiratory adenovirus infections among children in Northern Taiwan, 2009–2013. J Microbiol Immunol Infect. 2017;50:418‐426.</Citation></Reference><Reference><Citation>Jeon K, Lee SK, Jeong S, et al. Trends in the detection of viruses causing gastroenteritis over a 10‐year period and impact of nonpharmaceutical interventions. J Clin Virol. 2024;172:105676.</Citation></Reference><Reference><Citation>Maozhong L, Qin L, Cheng G, et al. Prospective surveillance of human adenovirus in acute respiratory infections reveals epidemiological features and the disappearance of species B during the COVID‐19 pandemic in Beijing, China. J Infect. 2022;85(4):436‐480.</Citation></Reference><Reference><Citation>Fangming W, Runan Z, Yuan Q, et al. The changed endemic pattern of human adenovirus from species B to C among pediatric patients under the pressure of non‐pharmaceutical interventions against COVID‐19 in Beijing, China. Virol J. 2023;20(1):4.</Citation></Reference><Reference><Citation>Dandan T, Yanhong S, Huihong X, Qing Y. The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant. J Med Virol. 2022;94(6):2376‐2383.</Citation></Reference><Reference><Citation>Fukuda Y, Togashi A, Hirakawa S, et al. A significant outbreak of respiratory human adenovirus infections among children aged 3‐6 years in Hokkaido, Japan, in 2023. J Med Virol. 2024;96:e29780.</Citation></Reference><Reference><Citation>Lee P‐I, Hsueh P‐R, Chuang J‐H, Liu M‐T. Changing epidemic patterns of infectious diseases during and after COVID‐19 pandemic in Taiwan. J Microbiol Immunol Infect. 2024;57:S1684118224001130. doi:10.1016/j.jmii.2024.07.002</Citation></Reference><Reference><Citation>Zhu G, Xu D, Zhang Y, et al. Epidemiological characteristics of four common respiratory viral infections in children. Virol J. 2021;18:10.</Citation></Reference><Reference><Citation>Mashael A, Aeshah A, Atheer AA, et al. Changes in seasonal respiratory viral infections among pediatric population around the COVID‐19 pandemic; 2019‐2023. Euro J Clin Microbiol Infecti Dis. 2024;43(8):1589‐1596.</Citation></Reference><Reference><Citation>Öner SZ, Kaleli̇ İ, Demi̇r M, Mete E, Çalişkan A. Rotavirus and adenovirus prevalence in patients with acute viral gastroenteritis in Denizli, Turkey, 2017‐2021. J Med Virol. 2022;94:3857‐3862.</Citation></Reference><Reference><Citation>Rl U, Sl K. Sex differences in respiratory viral pathogenesis and treatments. Ann Revi Virol. 2021;43(8):1589‐1596.</Citation></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626‐638.</Citation></Reference><Reference><Citation>Foley DA, Sikazwe CT, Minney‐Smith CA, et al. An unusual resurgence of human metapneumovirus in Western Australia following the reduction of Non‐Pharmaceutical interventions to prevent SARS‐CoV‐2 transmission. Viruses. 2022;14:2135.</Citation></Reference><Reference><Citation>Pengcheng L, Menghua X, Lijuan L, et al. The changing pattern of common respiratory and enteric viruses among outpatient children in Shanghai, China: two years of the COVID‐19 pandemic. J Med Virol. 2022;94(10):4696‐4703.</Citation></Reference><Reference><Citation>Ulrikka N, Ulla BH, Jens N, et al. Hospital admissions and need for mechanical ventilation in children with respiratory syncytial virus before and during the COVID‐19 pandemic: a Danish nationwide cohort study. Lancet Child Adole Health. 2023;7(3):171‐179.</Citation></Reference><Reference><Citation>Zhang Z‐Z, Chen DP, Liu QB, et al. Clinical features of Chinese children with COVID‐19 and other viral respiratory infections. Pediatr Pulmonol. 2022;57:49‐56.</Citation></Reference><Reference><Citation>Czarnowicki T, He H, Canter T, et al. Evolution of pathologic T‐cell subsets in patients with atopic dermatitis from infancy to adulthood. J Allergy Clin Immunol. 2020;145:215‐228.</Citation></Reference><Reference><Citation>Olin A, Henckel E, Chen Y, et al. Stereotypic immune system development in newborn children. Cell. 2018;174:1277‐1292.e14.</Citation></Reference><Reference><Citation>Ison MG, Hayden RT. Adenovirus. Microbiol Spect. 2016;4(4). doi:10.1128/microbiolspec.DMIH2-0020-2015</Citation></Reference><Reference><Citation>Troeger C, Forouzanfar M, Rao PC, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the global burden of disease study 2015. Lancet Infect Dis. 2017;17:1133‐1161.</Citation></Reference><Reference><Citation>Pagliano P, Sellitto C, Conti V, Ascione T, Esposito S. Characteristics of viral pneumonia in the COVID‐19 era: an update. Infection. 2021;49:607‐616.</Citation></Reference><Reference><Citation>Wang S, Zou X, Fu J, et al. Genotypes and phylogenetic analysis of human adenovirus in hospitalized pneumonia and influenza‐like illness patients in jiangsu province, China (2013‐2021). Infect Drug Resist. 2024;17:2199‐2211.</Citation></Reference><Reference><Citation>Dhingra A, Hage E, Ganzenmueller T, et al. Molecular evolution of human adenovirus (HAdV) species C. Sci Rep. 2019;9:1039.</Citation></Reference><Reference><Citation>Ismail AM, Cui T, Dommaraju K, et al. Genomic analysis of a large set of currently‐and historically‐important human adenovirus pathogens. Emerg Microbes Infect. 2018;7:1‐22.</Citation></Reference><Reference><Citation>Kajon AE, Lamson DM, Bair CR, et al. Adenovirus type 4 respiratory infections among civilian adults, northeastern United States, 2011‐20151. Emerg Infect Dis. 2018;24:201‐209.</Citation></Reference><Reference><Citation>Heo JY, Noh JY, Jeong HW, et al. Molecular epidemiology of human Adenovirus‐Associated febrile respiratory illness in soldiers, south Korea1. Emerg Infect Dis. 2018;24:1221‐1227.</Citation></Reference><Reference><Citation>Hang J, Kajon AE, Graf PCF, et al. Human adenovirus type 55 distribution, regional persistence, and genetic variability. Emerging Infect Dis. 2020;26:1497‐1505.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>